Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli
- 1 May 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 27 (5) , 569-575
- https://doi.org/10.1093/jac/27.5.569
Abstract
The influence of inoculum size, β-lactamase hyperproduction (multicopy plasmid) and modifications in the outer membrane protein profile on the susceptibility of Escherichia coli to combinations of amoxycillin/clavulanate, amoxycillin/sulbactam, amoxycillin/tazobactam and piperacillin/tazobactam were studied. For all combinations the bacterial susceptibility was affected by factors determining an increase in β-lactamase (inoculum size or hyperproduction). Clavulanic acid was the most efficient β-lactamase inhibitor. The absence of the outer membrane proteins, OmpF and OmpC, did not significantly affect susceptibility to the combinations per se but when combined with the presence of β-lactamase high MICs were observed. Seven out of eight amoxycillin/clavulanate resistant clinical isolates of E. coli had β-lactamase hyperproduction and a decrease or absence of OmpF.Keywords
This publication has 0 references indexed in Scilit: